Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
Clinical trial NCT00216099 · COMPLETED
Trial details
- NCT number
- NCT00216099
- Sponsor
- Christopher Sweeney, MBBS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.